WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 71 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $122,537 | – | 18,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,437,409 | 23.87% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $10,453,380 | 5.74% |
| MPM BioImpact LLC | 2,388,011 | $5,826,747 | 0.90% |
| PFM Health Sciences, LP | 3,241,074 | $7,908,221 | 0.39% |
| Eagle Health Investments LP | 700,000 | $1,708,000 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,529,416 | 0.21% |
| RA Capital Management | 6,144,881 | $14,993,510 | 0.20% |
| Rubric Capital Management LP | 1,333,893 | $3,254,699 | 0.08% |
| Murchinson Ltd. | 62,500 | $152,500 | 0.02% |
| Alpine Global Management, LLC | 37,551 | $91,624 | 0.02% |